Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arcadia Biosciences (RKDA) Accumulated Depreciation & Amortization (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Accumulated Depreciation & Amortization for 12 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Depreciation & Amortization rose 2.43% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Sep 2025, up 2.43%, and an annual FY2024 reading of $1.9 million, down 3.91% over the prior year.
  • Accumulated Depreciation & Amortization was $1.9 million for Q3 2025 at Arcadia Biosciences, roughly flat from $1.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.7 million in Q4 2021 and bottomed at -$612000.0 in Q1 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.8 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization plummeted 112.24% in 2023, then soared 502.29% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $5.7 million in 2021, then plummeted by 50.33% to $2.8 million in 2022, then crashed by 30.91% to $1.9 million in 2023, then decreased by 3.91% to $1.9 million in 2024, then rose by 1.66% to $1.9 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for RKDA at $1.9 million in Q3 2025, $1.9 million in Q2 2025, and $1.9 million in Q1 2025.